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Background: Misuse of codeine-containing medicines is an emerging public health issue.
Aims: We present the application of Liese and Franz’s (1996) cognitive developmental
model of substance abuse to the trajectory from legitimate codeine use for pain, towards
that of therapeutic and other forms of misuse, and physical and psychological dependence.
It illustrates a cognitive behavioural analysis of the experiences of codeine misusers – which
‘surfaces’ the specific beliefs, thoughts, emotions and behaviours of this group of hidden
codeine dependent individuals, who are distinct and unique from other opioid-dependent
cohorts. Method: In-depth one-to-one interviews with codeine misusers and dependent
individuals in Ireland (n = 21) and South Africa (n = 25) are analysed and applied to Liese
and Franz’s (1996) cognitive developmental model of substance abuse. Results: Misuse and
dependence pathways are maintained by the interplay between physiological determinants
relating to pain, withdrawal and tolerance, and psychological influences such as therapeutic
need, pre-empting of anticipated physical pain, pleasure from the dreamy sedative opiate
effect of codeine and relief of emotional distress. Progression towards habitual use and misuse
for therapeutic and intoxication purposes appears to be mediated by external environmental
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triggers pertaining to availability, internal meta-cognitions around physical pain and emotional
distress, and increasing importance of codeine in the life of the user. Conclusion: The concept
mapping of codeine misuse and dependence presented here could provide psychological
therapists working with individuals experiencing problems with codeine, misusing codeine
and those with iatrogenic dependence, with an enhanced understanding of the key concepts
involved in misuse and recovery pathways.
Keywords: codeine, pain, addiction, cognitive behavioural therapy, opioid
Introduction
Global trends in the misuse of prescription and over-the-counter (OTC) opioids are driven
by prescribing trends, forms of patient self-medication and public availability (Collins and
McAllister, 2006; Cooper, 2013a). Misuse definitions vary, but are broadly defined as ‘the use
of a medicine, with or without a doctor’s prescription, clearly outside of accepted medical
practice or guidelines, for recreational purposes or in the framework of self-medication, in
greater dosages or for longer periods than were prescribed, in which the risks and problems
associated with use outweigh the benefits’ (Casati et al., 2012, p. 230). Public misuse and
potential for misuse of codeine-containing medicines in particular has received attention in
recent times in Australia, the UK, Ireland, France and South Africa (McAvoy et al., 2011;
Stannard, 2013; Tobin et al., 2013; Nielsen et al., 2015c). Codeine, or 3-methylmorphine, is a
short-acting, weak to mid-range opiate (Tremlett et al., 2010). Codeine-containing medicines
are available (at the time of writing) in OTC formulations for the symptomatic relief of mild
to moderate pain or cough (Derry et al., 2013), and at varying strengths per country regulatory
regime (Van Hout and Norman, 2015c).
Typical side-effects of codeine include euphoria, altered perceptions and emotional
responses to pain, and sedation, and development of tolerance within relatively short time-
frames on repeated use (Romach et al., 1999; Sproule et al., 1999; Frei et al., 2010; Nielsen
et al., 2010; Babalonis et al., 2013). Harms relating to excessive and/or long-term use of
codeine-containing medicines are well documented (Robinson et al., 2010), and often occur
in individuals with no history of substance use disorders or co-morbidity (Van Hout et al.,
2014). Clinical profiles vary and are distinct from other opiate dependents, but include all ages,
genders, alcohol and poly-substance users, and patients with chronic pain and/or underlying
psychiatric conditions (Myers et al., 2003; Nielsen et al., 2008; Otto et al., 2009; Robinson
et al., 2010; Thekiso and Farren, 2010; Nielsen et al., 2011; Agyapong et al., 2013; Roussin
et al., 2013; Nielsen et al., 2015a,b). Problematic codeine users do not easily recognize
problematic use or dependence, and view themselves as different to other substance abusers
(Romach et al., 1999; Pates et al., 2002; Nielsen et al., 2010; Cooper, 2013b; Marr and Hill,
2015; Nielsen et al., 2015a).
Building on this ‘uniqueness’, we used concept mapping (Liese and Esterline, 2015) to
apply Liese and Franz’s (1996) cognitive developmental model of substance abuse to the
accounts of two groups of individuals from Ireland (Van Hout et al., 2015b) and South Africa
(Van Hout et al., 2015d) that experienced codeine use, misuse and dependence. Concept
mapping according to Liese and Esterline (2015) advocates case mapping which when shared
with the patient, can function as an intervention to support behaviour change by presenting
methodical generated graphic representations of the client’s dynamic relations and pathways
towards substance dependence. Ultimately this mapping exercise could be used to better
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integrate specific cognitive and behaviour change strategies for those experiencing codeine
misuse and dependence, and for therapists to better understand the unique challenges of
this OTC opiate drug as it relates to the role of feelings and emotions as influences for use,
environmental influences on behaviour change, and limits of self-control (Borland, 2014). We
chose the model designed by Liese and Franz (1996) as it is compatible within current opiate
substitution treatment (OST) and harm reduction approaches to treatment (Liese, 2014).
Method
Aim
The aim of this study was to apply Liese and Franz’s (1996) cognitive developmental model of
substance abuse to the in-depth narrative accounts of two samples of individuals from Ireland
and South Africa experiencing codeine misuse and dependence. Ethical approval in South
Africa was granted by the Ethics Committee of the South African Medical Research Council,
and by the Waterford Institute of Technology and the National Drug Treatment Centre Board
(NDTCB) in Ireland. Both studies were conducted in two very distinct regulatory regimes
and aimed to garner unique individual and collective lived experiences of codeine misuse and
dependence, from purposive samples of adult codeine misusers and individuals dependent
on codeine (actively misusing and in recovery) in Ireland (n = 21) and South Africa (n =
25). Sampling for both the Irish and South African studies continued until saturation of the
data occurred. We utilized extant narratives from these national studies and applied Liese and
Franz’s (1996) cognitive developmental model of substance abuse to concept map a cognitive
behavioural analysis of the experiences of codeine misusers – which ‘surfaces’ their specific
beliefs, thoughts, emotions and behaviours.
Selection of participants
Recruitment of participants was facilitated by the National Head Office of the South African
National Council on Alcoholism and Drug Dependence (SANCA) and the NDTCB in Ireland,
which oversee national addiction treatment systems in the respective countries. Both national
treatment organizations nominated key gatekeepers in each treatment centre to provide their
patients with information on the research study, and to ask if they wished to partake in an
interview. Informants were eligible for interview if they were: citizens of the country in which
the research was conducted (Ireland or South Africa), 18 years of age or more, reported using
codeine in excess of accepted medical guidelines, and scored five or more on the Severity of
Dependence Scale (SDS) (Gossop et al., 1995), a measure of the psychological components of
codeine dependence; a score of five or more on the SDS has been found to identify problematic
codeine use with a high degree of accuracy (Nielsen et al., 2010). The demographic profile of
the participants is reported in Table 1.
Interviews
Interviews lasted between 30 and 90 min, and were conducted in treatment and private
settings. The interview guide was developed based on the literature contained in an extensive
scoping review on codeine conducted by the team (Van Hout et al., 2014). Questions centred
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Table 1. Participant profile
Ireland South Africa
Gender Gender
57% female 40% female
43% male 60% male
Age range Age range
26–62 years 21–74 years
Mean age: 39 years Mean age: 43 years
Standard deviation 12.42 Standard deviation 9.93
Employment status Employment status
52% unemployed 64% unemployed
Use of codeine Use of codeine
72% used codeine within the last 12 months 80% used codeine within the last 12 months
90% reported codeine analgesics as primary
problematic drug
32% reported codeine analgesics as primary
problematic drug
20% reported codeine anti-tussive syrup as primary
problematic drug
SDS score SDS score
80% scored 10 or above 52% scored 10 or above
on participant choices and decision making to use codeine (prescribed or over-the-counter),
experience of sporadic and continued codeine use and misuse, reinforcers for use, misuse
and dependence, sourcing, awareness of risk and abuse potential, adverse consequences and
accessing of treatment services.
Analysis
Narratives were combined and analysed using the Empirical Phenomenological Psychological
(EPP) five-step method (Karlsson, 1995). This method was used to interpret the meaning
structure of lived psychological phenomena relating to the subjective codeine misuse
and dependence experience. A dialectic understanding of the whole picture and its part-
components was used to create an incremental understanding of the relationship between the
individual and the codeine-containing medicine. Above the thematic level, higher levels of
abstraction were grounded in user lack of awareness of habit-forming use, self-legitimization
of use and the pre-empting of physical pain, management of emotional distress, and the
invisible and isolating nature of dependence.
Psychological model of codeine misuse and dependence
Shaffer, LaPlante and Nelson (2012) and Shaffer et al. (2004) view addiction as a syndrome
with common causes, multiple opportunistic expressions, and with shared neurobiological
and psychosocial antecedents and experiences. This syndrome is cognisant of the role
of individual characteristics, drug used, and environmental factors influencing transitions
from use to misuse, and ultimately development of dependence. West (2005, 2013), whilst
recognizing the heterogeneous nature of mechanisms underlying addiction, underscores the
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effect of motivational dysfunction through the unstable presence of responses, reflexes,
impulses/inhibitory forces, desires, evaluations (beliefs), and overarching plans that interact
with the individual’s internal and external environment. Addictive behaviours (such as misuse
of codeine) are viewed by Beck et al. (1993) as emerging from interplay between layers
and levels of substance-related (anticipatory, relief-oriented and permissive) and facilitative
beliefs, and high-risk situations that activate automatic thoughts, and feelings of urges and
cravings to use, within a cycle of addiction.
A complex interaction between cognitions (beliefs, thoughts, schemas), opinions, expecta-
tions, values, suppositions, behaviours, emotions, social relationships, cultural influences and
physiological processes occurs (Alford and Nocross, 1991; Beck and Alford, 2000). Beck’s
cognitive model of addiction underpins cognitive therapy for substance use, through behavi-
oural strategies centring on avoiding high-risk situations, finding new coping mechanisms, and
working with substance-related beliefs. In Beck’s model, the expectancies of substances are
a key difference between those using problematically and those not, and with dysfunctional
beliefs playing a role in the generation of urges (Beck et al., 1993; Liese and Franz, 1996),
with beliefs and expectancies interacting with the emotional, environmental and physiological
systems, and facilitating the development and maintenance of the disorder (Liese et al., 1999).
The model, presented in Fig. 1, applies Liese and Franz’s (1996) cognitive developmental
model of substance abuse, to concept map the cognitive behavioural analysis of the distinct
and unique experiences of codeine misusers – which ‘surfaces’ their specific beliefs, thoughts,
emotions and behaviours around misuse and dependence on the legitimately used OTC
opiate drug, codeine. Liese and Franz’s (1996) model includes a developmental component
preceding the point of continued use activated by ‘activating stimuli’ (see Fig. 1). These earlier
factors include early life experiences, development of schemas, basic and conditional beliefs,
exposure to and experimentation with substances and the development of drug-related beliefs.
This developmental process can influence potential vulnerability for codeine use, misuse
and dependence. Seven stages are then depicted in the model of acute periods of codeine
use, misuse and dependence with individuals not necessarily following a linear trajectory
through the stages identified. The stages are: (1) activating stimuli for codeine use; (2) beliefs
activated; (3) automatic thoughts; (4) transitioning to codeine misuse and dependence (urges
and cravings); (5) enabling beliefs; (6) instrumental strategies; and (7) continued codeine
misuse and dependence (see Fig. 1).
Developmental stages of use and misuse
The developmental component before point of ‘continued use’ (see Fig. 1) explores early
life experiences, development of schemas, basic beliefs, exposure to and experimentation
with substances and the development of drug-related beliefs. Early life experiences reported
by participants centred on the ‘loss of a parent’ as a child and the emotional isolation
experienced (South African male, 45 years); ‘parental disharmony’ (South African female,
43 years; Irish male, 31 years) and its negative impact on children; history of parents with
substance misuse and dependence (South African male, 47 years; Irish male, 31 years; Irish
female, 42 years); parental physical and emotional abuse of children (South African male,
36 years; South African male, 47 years; Irish male, 31 years); history of childhood behavioural
problems and the use of medications to manage such challenging behaviours (South African
male, 42 years); ‘religion’ and associated beliefs formed and held that alcohol was forbidden
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Figure 1. (Colour online) Cognitive developmental model depicting use, misuse and dependence of
codeine containing medicines (adapted from: Liese and Franz, 1996)
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but it was acceptable to use drugs that were legitimately available to purchase OTC (South
African male, 45 years); to the ‘culture of sports’ and the social acceptance for some sports,
for example, ‘rugby’ and its association with ‘alcohol use and misuse’ (South African male,
37 years).
Such early life experiences led some participants to develop beliefs that negatively
impacted upon them, for example feeling ‘emotionally isolated’ resulted from parental loss,
or having ‘low self-esteem’ and feelings of worthlessness as a consequence of physical and
emotional abuse from parents who misused or were dependent on substances. Exposure to and
experimentation with substances occurred with many individuals reporting exposure ranging
from parental or sibling addictions to alcohol, nicotine and other substances to participants
themselves experimenting in the past as teenagers and young adults with ‘ecstasy, . . . speed,
(Irish female, 26 years) cannabis’ (Irish female, 26 years; Irish male, 38 years; Irish female,
42 years) and ‘cocaine’ (Irish male, 50 years) to their own legitimate use of OTC and
prescribed medications for physical conditions related to pain symptomology.
Specific positive drug-related beliefs were developed and maintained in relation to initial
codeine use. For example, some participants described how initial use of codeine-containing
medicines would make them feel more socially ‘relaxed’ (South African male, 37 years; South
African male, 41 years; South African male, 47 years; South African male, 74 years) similar
to the effects of alcohol, and also would enhance their self-confidence. One 31-year-old male
Irish participant describes how:
‘I was never confident enough . . . to just go out and talk to people . . . . And then when I was out, I
used to take codeine and . . . I would be very chatty. It’s almost like you’re drunk . . . ’
A 42-year-old male Irish participant highlights how over time he increased his use of codeine
to sustain feelings of confidence as were previously experienced:
‘ . . . three . . . just twenty four [codeine tablets] until they were gone but then I was getting to [the]
sixties and I wasn’t getting the effect anymore, well I was getting it a bit but I wasn’t . . . as confident
as I would be, . . . [then] . . . stretching up to eighty four [codeine tablets] . . . ’
In sum, early life experiences, social norms and schemas about the cultural acceptability of
drugs, combined with exposure to and experimentation with addictive behaviours appears to
lead to positive beliefs about codeine, which reinforces continued use.
Activating factors
We distinguish between internal and external precipitating factors that predispose the person
to risk for using codeine-containing medicines. Internal precipitating factors occur within the
individual, while external factors are contextualized beyond the individual’s psychobiography
and are situated either within relational or social contexts, or both. Examples of internal
factors are bio-psycho-social in origin and include individuals experiencing physical pain,
emotional distress, depression, anxiety, stress-related conditions, low self-esteem and a sense
of an ‘internalized loss’ of control resulting from adverse life events and the use of codeine
for reducing the perceived impact of psychological trauma.
External precipitating factors could include adverse life events such as lone parenting,
unemployment, marital and relationship disharmony and divorce. These experiences of
‘internalized loss’ lead to relational conflict within social networks, often resulting in social
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isolation and loss of support networks. Such internal and external precipitating factors are
situated within a wider context of the ‘legitimacy’ status of codeine products, ‘advertising
of products’, ‘pharmacy availability’ and ‘over the counter’ access to codeine-containing
medicines.
Beliefs activated
Many codeine-dependent individuals do not realize they are dependent. Anticipatory and
relief-oriented beliefs are formed as a consequence of internal and external activating factors.
Anticipatory beliefs that are convincingly held focus on the efficacy and pleasures associated
with use and misuse, whereby codeine is viewed as ‘my helper’ and ‘companion’. The
presence of emotional pain and self-legitimization of use is a common belief.
‘Pain killers are not just for what is written on the back of the pack, they should add also pain relief
from anxiety, depression and heartache.’ (Irish female, 26 years)
Automatic beliefs that codeine-containing medicines can ‘manage discrete episodes of
physical pain’, ‘deny or suppress psychological symptoms’ and ‘lift up moods’ are held.
Such beliefs range from relief-oriented beliefs, and involve the expectation of reprieve
from physical and emotional symptoms, for example helping them to relax, to beliefs
relating to mood elevation and regulation. Such automatic or involuntary thoughts sustain
the convincingly held beliefs that ‘codeine is my helper’ and ‘codeine is my companion’.
‘I wasn’t expecting the high I got but I was very happy with its effects, it felt like the missing piece
to my life.’ (Irish female, 26 years)
Automatic thoughts
Involuntary or automatic thoughts are described as a consequence to deeply held beliefs,
such as ‘codeine is my helper’ and ‘codeine is my companion’. Such beliefs contribute to the
development of the role of codeine as ‘crutch’, ‘friend’ and ‘helper’ in correspondence with
dependence and to the detriment of ‘real life social relations’. Automatic thoughts triggered
that are brief and spontaneous in relation to such basic beliefs include ‘feel better’, ‘improved
life’, ‘get them’ and ‘a rush’. As two Irish participants stated:
‘I always deep down knew I was abusing it but some of my thoughts were, so what? It’s serving
you a purpose, it’s making life better, it’s only an over the counter drug. I used it for just under a
year’ (Irish male, 30 years)
‘I used to take it [codeine tablets] then just to make myself feel better. When I used to get up and
feel crap, I’ll take it and feel instantly better. That is what I used to do. That is what I still do; and
now it’s like it has become part of my daily routine in my daily life. . . . I’d get very uplifted when
I was using that stuff [codeine tablets]’ (Irish male, 31 years)
Images as automatic thoughts were sometimes described, for example ‘fizzy effect’ following
use of soluble codeine medications and its pleasurable effects. One male participant described
how ‘soluble codeines in water with that fizzy effect . . . it gave me the hit and it gave me
a rush’ (Irish male, 38 years). This association between drugs-related beliefs and thoughts
lead the individual to desire codeine-containing medicines and ‘ . . . to consume in order
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to function throughout the day’. This creates a context whereby certain convincingly held
beliefs are maintained.
Transitioning to misuse and dependence
Many individuals described their use of codeine-containing medicines as appropriate and
consumed for legitimate reasons, prescribed or OTC and were largely unaware of codeine’s
abuse and dependence potential and the possible harms. Some are totally unaware of their
physical dependence to codeine, despite an increase in their use, desire to continue to misuse
and not being able to stop.
‘It creeps up on you particularly if you’ve got an addictive personality.’ (South African male,
38 years)
Awareness of habit-forming use and related tolerance is a gradual and subtle process
with often a sudden realization that they were consuming more than normal, sometimes
recreationally, with their ‘bodies’ experiencing withdrawal and requiring more codeine-
containing medicines. This pattern of use would ‘escalate’ especially as a result of on-going
life events negatively impacting upon their lives reinforced by beliefs that ‘codeine is my
helper’ and ‘codeine is my companion’. We failed to pinpoint any cultural or gender-related
differences in the codeine use, misuse and dependence pathway, and speculate that this is due
to the similarities in OTC availability, legitimization via prescriber and pharmacist routes of
supply, and tolerance of alcohol and other drugs by wider societal forces.
Enabling beliefs
Enabling beliefs are held which facilitate self-permissiveness or reinforce a sense of
entitlement to continue misusing codeine-containing medicines. Two specific enabling beliefs
were identified. The first centred on the misuse of codeine as a coping mechanism to manage
and pre-empt the occurrence of physical and psychological distress, in many cases relating to
severe trauma and distress.
‘Eventually there was not any pain, but I was scared of the pain in my mind.’ (South African male,
47 years)
‘Very quickly it was not enough in the morning to have me floating, feeling euphoric, and care free
really. I was numb and I liked that. Codeine filled a void.’ (Irish female, 32 years)
The second enabling belief highlights the importance of adverse social circumstances in
underpinning codeine dependence pathways, so justifying codeine misuse as a novel adaptive
coping mechanism for managing life stressors.
‘I actually abused the codeine to supress my depression and to give that euphoric effect. I felt a lot
of isolation, guilt and grief.’ (South African male, 36 years)
Instrumental strategies
Once individuals grant themselves permission to use codeine-containing medicines, their
focus moves to instrumental (behavioural and cognitive) strategies to secure the medicines
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either through legitimate sources (multiple pharmacy purchasing, ‘doctor hopping’) or via the
‘black market’. Participants explained:
‘ . . . .it became a very ingrained thing for me [to do].’ (South African male, 21 years)
‘An addiction will find a way, there’s always a way. When you want something you will always find
a way to get it.’ (Irish female, 45 years)
Legitimate sourcing involves behaviours that are deceptive and manipulative, involving lying,
faking illness or exaggerating symptoms to secure a script or supply of the medicine.
‘Exaggerating symptoms and manipulating the conversation. I always had an answer.’
(South African male, 38 years)
Habitual daily therapeutic and non-therapeutic use escalates with high dosages consumed
within a short time frame. This often occurs as a result of failure to develop alternative coping
strategies in relation to physical and emotional pain. Individuals recognize their problem with
regard to their daily use and misuse which leads in turn to ‘self-legitimization’ based upon
their need to use codeine inappropriately. This need to use inappropriately is reinforced by
a somatic ‘recognition of liking the opiate effect’, ‘pleasurable effects’ and ‘codeine giving
a buzz’ with increased tolerance to adverse effects such as withdrawals, medication overuse
headache, nausea, constipation, tachycardia and palpitations.
Continued misuse and dependence
Adopting instrumental (behavioural and cognitive) strategies, individuals are likely to
continue to source and use and misuse codeine leading to dependence.
‘Addiction teaches you master manipulation. No matter what barriers you build an addict’s mind
goes far beyond it.’ (Irish female, 26 years)
Beliefs held with conviction that ‘codeine is my helper’, ‘codeine is my companion’ and
‘self-legitimization’ reinforce their continued misuse and dependence. This process is further
reinforced by pre-existing internal and external precipitating factors that predispose them to
risk of using, misusing and dependence, and a ‘fear of stopping’.
‘My friends are gone and it’s more a companion addiction. It feels like it has its arm around you.
It gives me that sense of security and that’s what I’m struggling with at the moment, it’s to break
that cycle.’ (Irish male, 31 years)
Discussion
Liese and Franz’s (1996) cognitive developmental model of substance abuse is applied to
the in-depth narrative accounts of a sample of individuals experiencing codeine misuse and
dependence. A cognitive behavioural mapping of the psychological processes involved in
transitioning from codeine use, to misuse and towards dependence is presented. Illustrations
of the unique nature of these individuals’ experiences and pathways by virtue of codeine as
a legitimately sourced OTC opiate drug despite carrying risk of habitual and dependent use,
the accidental nature of inadvertent dependence, and interplay with various forms of physical
and emotional pain, which ultimately creates difficulties in successful recovery. Reinforcers,
triggers and thoughts are influenced by the thought processes around use, the pharmacy retail
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environment, and to a lesser extent, prescribing patterns. Ultimately we sought to create
greater understanding of codeine misuse and dependence in order to better inform the design
of appropriate psychological treatment plans within existing OST management systems. The
need to better understand and intervene with those requiring support for problematic codeine
use is well evidenced in contemporary literature (Pates et al., 2002; Nielsen et al., 2010; Marr
and Hill, 2015; Nielsen et al., 2015a).
Reliability and validity of the qualitative research process and the application of findings to
Liese and Franz’s (1996) cognitive developmental model of substance abuse are enhanced by
the trustworthiness of the data used (Lincoln and Guba, 1985), which contain extensive and
consistent similarities in the misuse and dependence phenomenon across the lived experiences
and social circumstances in both countries, one in the developed, and the other in the
developing world (Van Hout, et al., 2015b,d). Horizontal and vertical consistencies are visible
in the interpretation of the codeine misuse and dependence phenomena, despite variance in
cultural contexts, social circumstances and regulatory availability in each country. In terms
of ‘generalizability’ both qualitative studies were underpinned by a constructivist approach
that guided sampling, data collection and analysis and we do not claim that ‘generalizability’
was achieved. However, reliability of the data sources and validity of the model is further
supported by triangulation of these qualitative studies, and the generated model itself against
accounts of pathways to codeine misuse reported by other studies conducted in the UK
(Cooper, 2011, 2013b), and Australia (Nielsen et al., 2010, 2011, 2013).
Borland (2014) advocates the need to consider how a ‘hard to maintain’ behaviour is
maintained, whether by the skills required to perform it, reinforcement patterns, cognitive
thought processes, environmental factors, or a multiplicity of these factors, and that such
behaviour is often not available for conscious awareness. Codeine misuse and dependence
pathways appear to be maintained by the interplay between physiological determinants
relating to pain, withdrawal and tolerance, and psychological influences. These influences
include therapeutic need and use pre-empting of anticipated physical pain, recognition of
appreciation of the opiate sedative therapeutic effect both for legitimate therapeutic and non-
therapeutic reasons. Iatrogenic dependence contributes to the blurring between therapeutic
use and problematic use of codeine-containing medicines. Progression towards habitual use,
dose escalation and medication of withdrawal and anxiety-related symptoms appears to be
mediated by external environmental triggers pertaining to availability, and internal meta-
cognitions around physical pain and emotional distress, and the significance of the role
codeine assumes for the user.
Given codeine users’ unique experiences with a legitimately available opiate drug, lack
of self-identification of habit-forming use and pathways towards dependence, those patients
do require psychological treatment interventions particular to their needs and in order for
recovery to occur (Kean, 2015; Nielsen et al., 2011, 2015c; Van Hout et al., 2015a). The
recognition of iatrogenic dependence in these patients warrants particular psycho-social
interventions alongside the management of pain (Hard, 2014; Marr and Hill, 2015). Targeted
psycho-social cognitive-based interventions are warranted for this distinct group of opiate
dependents (Kean, 2015; Van Hout et al., 2015a,b,d) and particularly those that target client
conscious awareness of transitioning of misuse towards dependence (Borland, 2014; West,
2005, 2013). The model is intended to help therapists integrate cognitive and behaviour
change strategies (for example mindfulness and acceptance), with an understanding of the
distinct challenges for these patients in navigating pharmacies when in recovery, the role
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of trauma and distress in increasing their vulnerability, and coping mechanisms needed for
successful rehabilitation. The role of codeine-containing medicines appears grounded in self-
regulation vulnerabilities (Khantzian, 1997; Nielsen et al., 2010). Cognitive conceptualization
can thus be reformulated during therapy, whilst gathering additional client information,
experiences and evidence. Physiological, behavioural and social triggers, along with the
interplay of anticipatory, relief-oriented and permissive beliefs can contribute to relapse, even
in the absence of physiological symptoms such as pain.
Conclusion
Psychological interventions for codeine dependence should take account of the reinforcing
cycles of physical pain, emotional distress and codeine misuse. This model could provide
psychological therapists working with individuals experiencing problems with codeine,
misusing codeine and those with iatrogenic dependence with an enhanced understanding of
the key concepts involved in these unique dependence and recovery pathways.
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